CMS-HCC Risk Adjustment · Retired V24 Model 110 Codes

V24 HCC 9 (Archived Category) ICD-10-CM

HCC 9 is a payment category of the retired CMS-HCC V24 model, which last determined Medicare Advantage payment in 2025. The 110 ICD-10-CM codes below are its final mappings, kept for lookback analysis and RADV audit reference. Each code shows where it maps in the live V28 model.

✗ Retired model · not used for current Medicare Advantage paymentLast paid PY 2025 · kept for lookback and RADV reference
110
ICD-10-CM Codes
110
Still Risk-Adjust in V28
0
No V28 Successor
PY 2025
Last Paid Year
CMS-HCC V24

Archived Codes of V24 HCC 9 110 codes

110 of 110 shown
  • C15.3 Malignant neoplasm of upper third of esophagus now HCC 20
  • C15.4 Malignant neoplasm of middle third of esophagus now HCC 20
  • C15.5 Malignant neoplasm of lower third of esophagus now HCC 20
  • C15.8 Malignant neoplasm of overlapping sites of esophagus now HCC 20
  • C15.9 Malignant neoplasm of esophagus, unspecified now HCC 20
  • C16.0 Malignant neoplasm of cardia now HCC 20
  • C16.1 Malignant neoplasm of fundus of stomach now HCC 20
  • C16.2 Malignant neoplasm of body of stomach now HCC 20
  • C16.3 Malignant neoplasm of pyloric antrum now HCC 20
  • C16.4 Malignant neoplasm of pylorus now HCC 20
  • C16.5 Malignant neoplasm of lesser curvature of stomach, unspecified now HCC 20
  • C16.6 Malignant neoplasm of greater curvature of stomach, unspecified now HCC 20
  • C16.8 Malignant neoplasm of overlapping sites of stomach now HCC 20
  • C16.9 Malignant neoplasm of stomach, unspecified now HCC 20
  • C17.0 Malignant neoplasm of duodenum now HCC 20
  • C17.1 Malignant neoplasm of jejunum now HCC 20
  • C17.2 Malignant neoplasm of ileum now HCC 20
  • C17.3 Meckel's diverticulum, malignant now HCC 20
  • C17.8 Malignant neoplasm of overlapping sites of small intestine now HCC 20
  • C17.9 Malignant neoplasm of small intestine, unspecified now HCC 20
  • C22.0 Liver cell carcinoma now HCC 20
  • C22.1 Intrahepatic bile duct carcinoma now HCC 20
  • C22.2 Hepatoblastoma now HCC 20
  • C22.3 Angiosarcoma of liver now HCC 20
  • C22.4 Other sarcomas of liver now HCC 20
  • C22.7 Other specified carcinomas of liver now HCC 20
  • C22.8 Malignant neoplasm of liver, primary, unspecified as to type now HCC 20
  • C22.9 Malignant neoplasm of liver, not specified as primary or secondary now HCC 20
  • C23 Malignant neoplasm of gallbladder now HCC 20
  • C24.0 Malignant neoplasm of extrahepatic bile duct now HCC 20
  • C24.1 Malignant neoplasm of ampulla of Vater now HCC 20
  • C24.8 Malignant neoplasm of overlapping sites of biliary tract now HCC 20
  • C24.9 Malignant neoplasm of biliary tract, unspecified now HCC 20
  • C25.0 Malignant neoplasm of head of pancreas now HCC 20
  • C25.1 Malignant neoplasm of body of pancreas now HCC 20
  • C25.2 Malignant neoplasm of tail of pancreas now HCC 20
  • C25.3 Malignant neoplasm of pancreatic duct now HCC 20
  • C25.4 Malignant neoplasm of endocrine pancreas now HCC 20
  • C25.7 Malignant neoplasm of other parts of pancreas now HCC 20
  • C25.8 Malignant neoplasm of overlapping sites of pancreas now HCC 20
  • C25.9 Malignant neoplasm of pancreas, unspecified now HCC 20
  • C33 Malignant neoplasm of trachea now HCC 20
  • C34.00 Malignant neoplasm of unspecified main bronchus now HCC 20
  • C34.01 Malignant neoplasm of right main bronchus now HCC 20
  • C34.02 Malignant neoplasm of left main bronchus now HCC 20
  • C34.10 Malignant neoplasm of upper lobe, unspecified bronchus or lung now HCC 20
  • C34.11 Malignant neoplasm of upper lobe, right bronchus or lung now HCC 20
  • C34.12 Malignant neoplasm of upper lobe, left bronchus or lung now HCC 20
  • C34.2 Malignant neoplasm of middle lobe, bronchus or lung now HCC 20
  • C34.30 Malignant neoplasm of lower lobe, unspecified bronchus or lung now HCC 20
  • C34.31 Malignant neoplasm of lower lobe, right bronchus or lung now HCC 20
  • C34.32 Malignant neoplasm of lower lobe, left bronchus or lung now HCC 20
  • C34.80 Malignant neoplasm of overlapping sites of unspecified bronchus and lung now HCC 20
  • C34.81 Malignant neoplasm of overlapping sites of right bronchus and lung now HCC 20
  • C34.82 Malignant neoplasm of overlapping sites of left bronchus and lung now HCC 20
  • C34.90 Malignant neoplasm of unspecified part of unspecified bronchus or lung now HCC 20
  • C34.91 Malignant neoplasm of unspecified part of right bronchus or lung now HCC 20
  • C34.92 Malignant neoplasm of unspecified part of left bronchus or lung now HCC 20
  • C38.4 Malignant neoplasm of pleura now HCC 20
  • C45.0 Mesothelioma of pleura now HCC 19
  • C45.1 Mesothelioma of peritoneum now HCC 19
  • C45.2 Mesothelioma of pericardium now HCC 19
  • C45.7 Mesothelioma of other sites now HCC 19
  • C45.9 Mesothelioma, unspecified now HCC 19
  • C48.0 Malignant neoplasm of retroperitoneum now HCC 20
  • C48.1 Malignant neoplasm of specified parts of peritoneum now HCC 20
  • C48.2 Malignant neoplasm of peritoneum, unspecified now HCC 20
  • C48.8 Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum now HCC 20
  • C90.00 Multiple myeloma not having achieved remission now HCC 19
  • C90.01 Multiple myeloma in remission now HCC 19
  • C90.02 Multiple myeloma in relapse now HCC 19
  • C90.10 Plasma cell leukemia not having achieved remission now HCC 19
  • C90.11 Plasma cell leukemia in remission now HCC 19
  • C90.12 Plasma cell leukemia in relapse now HCC 19
  • C90.20 Extramedullary plasmacytoma not having achieved remission now HCC 19
  • C90.21 Extramedullary plasmacytoma in remission now HCC 19
  • C90.22 Extramedullary plasmacytoma in relapse now HCC 19
  • C92.10 Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission now HCC 22
  • C92.11 Chronic myeloid leukemia, BCR/ABL-positive, in remission now HCC 22
  • C92.12 Chronic myeloid leukemia, BCR/ABL-positive, in relapse now HCC 22
  • C92.20 Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission now HCC 20
  • C92.21 Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission now HCC 20
  • C92.22 Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse now HCC 20
  • C92.30 Myeloid sarcoma, not having achieved remission now HCC 17
  • C92.31 Myeloid sarcoma, in remission now HCC 17
  • C92.32 Myeloid sarcoma, in relapse now HCC 17
  • C92.90 Myeloid leukemia, unspecified, not having achieved remission now HCC 20
  • C92.91 Myeloid leukemia, unspecified in remission now HCC 20
  • C92.92 Myeloid leukemia, unspecified in relapse now HCC 20
  • C92.Z0 Other myeloid leukemia not having achieved remission now HCC 20
  • C92.Z1 Other myeloid leukemia, in remission now HCC 20
  • C92.Z2 Other myeloid leukemia, in relapse now HCC 20
  • C93.10 Chronic myelomonocytic leukemia not having achieved remission now HCC 20
  • C93.11 Chronic myelomonocytic leukemia, in remission now HCC 20
  • C93.12 Chronic myelomonocytic leukemia, in relapse now HCC 20
  • C93.30 Juvenile myelomonocytic leukemia, not having achieved remission now HCC 20
  • C93.31 Juvenile myelomonocytic leukemia, in remission now HCC 20
  • C93.32 Juvenile myelomonocytic leukemia, in relapse now HCC 20
  • C93.90 Monocytic leukemia, unspecified, not having achieved remission now HCC 20
  • C93.91 Monocytic leukemia, unspecified in remission now HCC 20
  • C93.92 Monocytic leukemia, unspecified in relapse now HCC 20
  • C93.Z0 Other monocytic leukemia, not having achieved remission now HCC 20
  • C93.Z1 Other monocytic leukemia, in remission now HCC 20
  • C93.Z2 Other monocytic leukemia, in relapse now HCC 20
  • C94.30 Mast cell leukemia not having achieved remission now HCC 20
  • C94.31 Mast cell leukemia, in remission now HCC 20
  • C94.32 Mast cell leukemia, in relapse now HCC 20
  • C94.80 Other specified leukemias not having achieved remission now HCC 20
  • C94.81 Other specified leukemias, in remission now HCC 20
  • C94.82 Other specified leukemias, in relapse now HCC 20

Questions About This Archived Category

Is V24 HCC 9 still paid?

No. The CMS-HCC V24 model last determined Medicare Advantage payment in 2025; from payment year 2026 the V28 model pays 100% of the risk score. This page exists for lookback analysis and RADV audit periods that predate the transition.

Where did these codes go in V28?

Each row above names the code's live V28 category. The category-level picture, with destination counts for every V24 category, is on V24 to V28: What Changed.

Related References

Source: Centers for Medicare & Medicaid Services, Payment Year 2026 risk adjustment mapping and model software releases (CMS-HCC V28; CMS-HCC V24 from the last published V24 mappings, payment year 2025), applied to the FY 2026 ICD-10-CM code set. ICD List is not affiliated with CMS.